Revenue: As of FY2025 Q1, the actual value is USD 28.69 M.

EPS: As of FY2025 Q1, the actual value is USD -0.02.

EBIT: As of FY2025 Q1, the actual value is USD -431 K.

Segment Revenue

• Total Sales: Sales increased 52.4% to approximately $28.7 million for the three months ended March 31, 2025, from approximately $18.8 million for the same period in 2024.
• Stran Segment Sales: Sales increased to approximately $20.9 million from approximately $18.8 million YoY.
• SLS Segment Sales: Sales increased to approximately $7.8 million from $0 due to the acquisition of the Gander Group assets.

Operational Metrics

• Gross Profit: Increased 51.1% to approximately $8.5 million, or 29.6% of sales, from approximately $5.6 million, or 29.8% of sales YoY.
• Operating Expenses: Increased 43.6% to approximately $9.0 million from approximately $6.3 million YoY.
• Net Loss: Net loss for the three months ended March 31, 2025 was approximately $0.4 million, compared to approximately $0.5 million YoY.

Cash Flow

• Cash and Cash Equivalents: Approximately $4.2 million as of March 31, 2025, down from $9.4 million as of December 31, 2024.

Unique Metrics

• Gross Profit Margin: The gross profit margin for the Stran segment increased to 32.4% from 29.8% YoY, while the SLS segment had a gross profit margin of 21.8%.

Outlook / Guidance

• Stran is focused on executing its strategy with precision, enhancing operational efficiency, and expanding margins. The company is well-positioned to support growth initiatives with a strong balance sheet, including approximately $12.2 million in cash, cash equivalents, and investments.